| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.03 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |